STAGE IIIB FALLOPIAN TUBE CANCER AJCC V7
Clinical trials for STAGE IIIB FALLOPIAN TUBE CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB FALLOPIAN TUBE CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIB FALLOPIAN TUBE CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Ovarian cancer study tests which chemo combo works best
Disease control OngoingThis study compares two chemotherapy regimens (carboplatin+paclitaxel vs oxaliplatin+capecitabine), with or without the drug bevacizumab, as first treatment for mucinous ovarian or fallopian tube cancer. About 50 participants with newly diagnosed or recurrent disease are enrolled…
Matched conditions: STAGE IIIB FALLOPIAN TUBE CANCER AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:57 UTC
-
Weekly chemo may improve outcomes for advanced ovarian cancer patients
Disease control OngoingThis study tested two different ways of giving the chemotherapy drug paclitaxel (either once every three weeks or once a week) along with carboplatin, with or without the targeted drug bevacizumab, in 692 people with advanced ovarian, peritoneal, or fallopian tube cancer. The goa…
Matched conditions: STAGE IIIB FALLOPIAN TUBE CANCER AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Ovarian cancer patients get immune boost in new drug trial
Disease control OngoingThis early-phase study tested whether adding the immunotherapy drug durvalumab to standard chemotherapy helps women with advanced ovarian, fallopian tube, or primary peritoneal cancer. 18 participants received the combination to see how it affects the immune system and tumor grow…
Matched conditions: STAGE IIIB FALLOPIAN TUBE CANCER AJCC V7
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Heated chemo during surgery shows promise for Tough-to-Treat ovarian cancer
Disease control OngoingThis early-phase study tests whether giving a dose of heated chemotherapy directly into the abdomen during surgery can help lower the risk of cancer returning in people with advanced ovarian, fallopian tube, uterine, or peritoneal cancer. About 40 participants with stage III or I…
Matched conditions: STAGE IIIB FALLOPIAN TUBE CANCER AJCC V7
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
New drug duo targets Hard-to-Treat brain tumors
Disease control OngoingThis early-phase trial tests a new drug (MLN0128) combined with bevacizumab in people with recurrent glioblastoma (a brain cancer) or other advanced solid tumors that have stopped responding to standard treatments. The main goals are to find the safest dose and understand side ef…
Matched conditions: STAGE IIIB FALLOPIAN TUBE CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Ovarian cancer drug trial tests DNA changes before surgery
Knowledge-focused OngoingThis early-phase trial is testing how the drug adavosertib affects the DNA of tumor cells in 38 people with advanced ovarian, fallopian tube, or peritoneal cancer before they have surgery. The goal is to learn how the drug changes the cancer's DNA, which may help doctors plan bet…
Matched conditions: STAGE IIIB FALLOPIAN TUBE CANCER AJCC V7
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 05:49 UTC